Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Revilico helps researchers shorten the drug discovery timeline by combining computational design with direct experimental validation. The company operates an end-to-end drug discovery platform that…

Revilico helps researchers shorten the drug discovery timeline by combining computational design with direct experimental validation. The company operates an end-to-end drug discovery platform that…
What they do: End-to-end computational-to-experimental drug-discovery platform (Revilico OS) for small-molecule discovery
Founded: 2024
Stage / funding: Pre-seed; multiple early rounds
HQ: Los Angeles, California, United States
Team size (reported): ~20 employees
Drug discovery for small molecules; computational and experimental workflows for therapeutic candidate identification and optimization.
2024
Biotechnology
Most recent pre-seed round reported on March 10, 2025
Second early pre-seed round reported (multiple pre-seed rounds listed)
“Backed by institutional investors including Forum Ventures and Right Side Capital Management”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week